Skip to main content
3SBio Inc. (HKG:1530)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
29.58
-0.14 (-0.47%)
At close: Dec 5, 2025

3SBio Revenue

3SBio had revenue of 4.36B CNY in the half year ending June 30, 2025, with 15.11% growth. This brings the company's revenue in the last twelve months to 9.07B, up 7.75% year-over-year. In the year 2024, 3SBio had annual revenue of 9.11B with 16.53% growth.

Revenue (ttm)
9.07B CNY
Revenue Growth
+7.75%
P/S Ratio
7.12
Revenue / Employee
1.63M CNY
Employees
5,577
Market Cap
70.76B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.11B1.29B16.53%
Dec 31, 20237.82B950.20M13.84%
Dec 31, 20226.87B483.73M7.58%
Dec 31, 20216.38B794.37M14.22%
Dec 31, 20205.59B269.55M5.07%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeOne Medicines AG 38.69B
Hansoh Pharmaceutical Group Company 14.45B
JD Health International 71.34B
Innovent Biologics 12.52B
WuXi Biologics 21.98B
Sino Biopharmaceutical 33.49B
Akeso 2.75B
Sichuan Kelun-Biotech Biopharmaceutical 1.64B
Revenue Rankings

3SBio News

More News